Tuberous Sclerosis clinical trials at UCSF
3 in progress, 1 open to eligible people
Tuberous sclerosis is a medical condition causing tumors in different parts of the body. UCSF is conducting a clinical trial called "PRECISION 1" for adults and adolescents with malignant solid tumors caused by genetic alterations in TSC1/TSC2 genes. There are two other trials in progress, but not accepting new participants.
Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
open to eligible people ages 12 years and up
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes
San Francisco, California and other locations
TSC Biosample Repository and Natural History Database
Sorry, not currently recruiting here
The TSC Biosample Repository collects and stores samples of blood, DNA, and tissues that scientists can request to use in their research. The samples we collect are all linked to clinical data in the TSC Natural History Database. The TSC Natural History Database captures clinical data to document the impact of the disease on a person's health over his or her lifetime. This data may be collected retrospectively or prospectively.
Oakland, California and other locations
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the long-term safety in patients with TSC and refractory seizures who are currently receiving everolimus treatment in the Novartis-sponsored EXIST-3 study and who are determined to be benefiting from continued treatment as judged by the investigator at the completion of EXIST-3
Oakland, California and other locations
Our lead scientists for Tuberous Sclerosis research studies include Brian Schulte, MD.
Last updated: